Please login to the form below

Not currently logged in


This page shows the latest Shingrix news and features for those working in and with pharma, biotech and healthcare.

GSK’s revenue drops by 18% in Q1 as performance pressures mount

GSK’s revenue drops by 18% in Q1 as performance pressures mount

Shingrix. Walmsley pinned GSK’s growth prospects on the launch of its HIV pill Cabenuva, as well as a potential RSV vaccine, currently in phase 3 trials, and a new ... GSK is confident that sales of Shingrix will increase in the second half of the year,

Latest news

More from news
Approximately 9 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    contain the adjuvant QS-21 Stimulon.  In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.  GSK's malarial vaccine, Mosquirix which also contains

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

Stick or Twist? Healthcare brands in a (post) COVID-19 world
Stick or twist? Looking at the patient experience as we emerge from the COVID pandemic
Lockdown entertainment or healthcare revolution? The role of video games in healthcare